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Abstract
Background: Oxidative capacity is decreased in type 2 diabetes. Whether decreased oxidative capacity is a cause or
consequence of diabetes is unknown. Our purpose is to evaluate whether lactate, a marker of oxidative capacity, is
associated with incident diabetes.
Methods and Findings: We conducted a case-cohort study in the Atherosclerosis Risk in Communities (ARIC) study at year 9
of follow-up. We evaluated lactate’s association with diabetes risk factors at baseline and estimated the hazard ratio for
incident diabetes by quartiles of plasma lactate in 544 incident diabetic cases and 533 non-cases. Plasma lactate showed a
graded positive relationship with fasting glucose and insulin (P,0.001). The relative hazard for incident diabetes increased
across lactate quartiles (P-trend #0.001). Following adjustment for demographic factors, medical history, physical activity,
adiposity, and serum lipids, the hazard ratio in the highest quartile was 2.05 times the hazard in the lowest quartile (95% CI:
1.28, 3.28). After including fasting glucose and insulin the association became non-significant.
Conclusions: Lactate, an indicator of oxidative capacity, predicts incident diabetes independent of many other risk factors
and is strongly related to markers of insulin resistance. Future studies should evaluate the temporal relationship between
elevated lactate and impaired fasting glucose and insulin resistance.
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Introduction
In the United States, the prevalence of type 2 diabetes is high
[1] and its incidence is increasing due to rising levels of adiposity.
Prior to the clinical diagnosis of diabetes, individuals undergo a
period of subclinical insulin resistance [2]. Accumulating evidence
suggests that low oxidative capacity due to impaired mitochondrial
oxidative phosphorylation [3] is associated with insulin resistance
and type 2 diabetes. It is unclear, however, whether low oxidative
capacity is a cause or consequence of diabetes [4]. This question
can be addressed using markers of oxidative capacity in
longitudinal studies of incident diabetes.
Blood lactate is a measure of the gap between energy
expenditure and oxidative capacity. Lactate is produced by
anaerobic glycolysis in muscle, adipose, and other tissues.
Anaerobic glycolysis, and, therefore, lactate production increase
when energy demand exceeds mitochondrial oxidative capacity.
Traditionally, blood lactate is used as a clinical marker of ischemia
and as a measure of fitness among exercising individuals. Lactate
variation in resting individuals may also be informative, however.
Elevated lactate may be observed with mitochondrial impairments
in oxidative phosphorylation [5,6] and several clinical studies have
demonstrated that lactate is closely related to insulin resistance [7–
9]. In addition, a number of observational studies have shown that
lactate is associated fasting glucose, fasting insulin, and the
prevalence of type 2 diabetes [10–12]. These studies, however,
were limited by cross-sectional designs. Only one prospective study
in white men studied the association between plasma lactate levels
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and incident diabetes. This study showed that the highest quintile
of lactate at baseline was associated with 2.4 (95% CI: 1.0–5.9)
times the risk of developing diabetes in the lowest quintile [13].
Therefore, we examined the longitudinal association of plasma
lactate with subsequent development of type 2 diabetes in a




ARIC is a community-based prospective cohort study of 15,792
adults, ages 45–64. ARIC participants were identified by
probability sampling from 4 U.S. communities (Forsyth County,
North Carolina; Jackson, Mississippi; suburban Minneapolis,
Minnesota; and Washington County, Maryland) and were
enrolled between 1987 and 1989 [14–16]. Study participants
returned for three follow-up visits in 1990–1992, 1993–1995, and
1996–1998, during which time incident diabetes was determined.
Response rates for each ARIC visit were 60% (visit 1), 93% (visit
2), 86% (visit 3), and 80% (visit 4). The study protocol was
approved by institutional review boards at each clinical site,
namely, the IRBs of the University of Minnesota, Johns Hopkins
University, University of North Carolina, University of Mississippi
Medical Center, and Wake Forest University. Written consent was
obtained from all ARIC participants.
We used a case-cohort design described previously [17]. We
excluded participants with a diagnosis of diabetes at baseline
(n = 2,018), members of ethnic groups with a small sample size
(n = 95), participants whose diabetes status could not be deter-
mined in any of the three follow-up visits (n = 879), participants
lacking a valid diabetes determination (n = 26), participants with
missing plasma samples, anthropometic data, or related covariate
data (hypertension, smoking, etc.) at baseline (n = 2,526), and non-
fasting individuals at baseline (n = 212). Of the remaining 9,740
subjects, 1,105 developed diabetes during the 9-yr follow-up
period. From this population, we selected a random cohort sample
(n = 637) and a random incident diabetes case sample (n = 552)
according to strata determined by race. Among those in the
random cohort sample, 94 (14.8%) developed diabetes during the
follow-up period. Of this population, an additional 7 non-case
participants in the random cohort sample and 11 participants in
the diabetes case sample did not have a lactate measurement and
were excluded. After these exclusions, baseline covariates were
compared between both the case-cohort and the complete cohort
of ARIC visit 1 and found to be nearly identical.
Plasma Lactate
We measured plasma lactate in stored samples originally
collected in 1987–1989 and frozen at 270uC. Lactate was
quantified with a Roche Hitachi 911 auto-analyzer, using an
enzymatic reaction that converts lactate to pyruvate [18]. Quality
control assessments of the assays suggested an inter-assay
coefficient of reliability of 0.93 and a coefficient of variation of
9.2% [12].
Primary Outcome: Incident Diabetes
Participants were assessed for a diagnosis of diabetes at baseline
and at each of the three follow-up visits. Incident diabetes was
classified as a diabetic case if a participant fulfilled any one of the
following conditions: (1) a fasting glucose $7.0 mmol/liter, (2) a
nonfasting glucose $11.1 mmol/liter, (3) use of a diabetes
medication, or (4) self-reported physician diagnosis. For individ-
uals diagnosed by a glucose measurement, the date of diagnosis
was estimated under the assumption that glucose increased at a
linear rate between visits. This linear approximation was used to
estimate the time of actual diabetes onset. Similarly, the date of
diagnosis for cases identified by medication use or physician
diagnosis was estimated assuming a linear increase in glucose from
their last diabetes-free visit [19]. As a sensitivity analysis, we
restricted our diagnosis of incident diabetes to diabetes medication
use or self-report of physician diagnosis, excluding the subclinical
cases of diabetes indentified by glucose measures.
Other Covariates
We included a number of covariates assessed at the baseline visit
of ARIC that were known to be associated with diabetes.
Definitions and methods for the assessment of these covariates
were described previously [20,21]. In brief, the following
laboratory measurements were treated as continuous variables:
low density lipoprotein (LDL) cholesterol, high density lipoprotein
(HDL) cholesterol, triglycerides, fasting glucose, and fasting
insulin. Triglycerides and insulin were log-base 10 transformed
to normalize their distributions. We also determined the homeo-
static model assessment insulin resistance index (HOMA-IR) by
((fasting insulin in pmol/L)/6.945*(fasting glucose in mg/dL))/
405.
With regard to physical examination covariates, we determined
body mass index (kg/m2) from height and weight measurements
and measured waist circumference at the umbilical level. Smoking
status (never, current, former), education (,12 years, $12 years),
and leisure time physical activity index (ordinal integer ranging
from 1 to 4) were based on replies to the Baecke Physical Activity
questionnaire. Prevalent coronary heart disease (yes or no) was
based on past history of myocardial infarction, heart or arterial
surgery, coronary bypass, or angioplasty. Parental history of
diabetes (yes or no) was defined by a diagnosis of diabetes in a
participant’s father or mother. Hypertension (yes or no) was
defined as either a systolic blood pressure measurement
$140 mmHg, a diastolic blood pressure measurement
$90 mmHg, or use of high blood pressure medications in the
past 2 weeks.
Statistical Analysis
All analyses and plots were weighted to account for the random
cohort sample and the random case sample using the svy
command and pweights in Stata 11.1 (StataCorp LP, College
Station, TX), which entail inverse weighting of the observations
according to the case-cohort sampling design [20]. Proportions
and mean baseline characteristics of the study participants were
reported by lactate quartiles, where lactate quartile categories were
based on measurements in the random cohort sample. Standard
errors were estimated using the Taylor series (linearization)
method. We performed a cross-sectional analysis of the association
between log-base 10 transformed lactate and physiologic correlates
of insulin resistance, namely, BMI, waist circumference, log-base
10 transformed triglycerides, HDL cholesterol, fasting glucose, and
log-base 10 transformed fasting insulin. Comparisons were made
using linear regression and Pearson’s correlation coefficients. The
HOMA-IR was plotted by lactate quartiles to further examine the
relationship between lactate and lipids or glycemia. The P-value
for the trend between HOMA-IR and lactate quartiles were
calculated with linear regression, treating the median value of each
lactate quartile as an ordinal variable.
A Kaplan-Meier cumulative incidence plot was utilized to
visualize the relationship between baseline lactate measurements
and risk of incident diabetes, using follow-up time as the time axis.
A Wald test was used to evaluate for a trend across quartiles of
Lactate and Incident Diabetes
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lactate. The association between lactate quartiles and incident
diabetes was further examined in nested Cox proportional hazards
models that (1) addressed factors associated with both diabetes and
lactate, and (2) explored the metabolic pathway relating lactate
with incident diabetes by adjusting for the same factors above
along with insulin and glucose. In the first series of models, we
adjusted for age, gender, race, ARIC center, and education
(Model 1); a diagnosis of hypertension, prevalent coronary heart
disease, smoking status, leisure index, and parental history of
diabetes (Model 2); BMI and waist circumference (Model 3); and
log10-transformed triglycerides, LDL cholesterol, and HDL
cholesterol (Model 4). In our metabolic pathway models, we
adjusted for fasting glucose (Model 5a), fasting insulin (Model 5b)
and both (Model 5c) in addition to the preceding covariates.
Furthermore, we generated histograms of the distribution of
lactate among diabetic cases and noncases and overlaid a
restricted cubic spline based on Model 4 with knots at each
lactate quartile to visualize the risk association.
Results
The geometric mean for plasma lactate in the entire study
sample (N = 1,077) was 7.67 mg/dL (IQR: 5.80 to 9.70 mg/dL;
max: 36.1 mg/dL) (Table 1); plasma lactate was less than 18 mg/
dL (,2 mmol/L) in 97% of the population. Age was not related to
lactate concentration (P = 0.55). However, the proportion of
African Americans and men increased across lactate quartiles (P-
trends of 0.03 and ,0.001, respectively). The prevalence of
hypertension was also greater in higher lactate quartiles, ranging
from 13.9% to 34.2% (P-trend ,0.001). Lifestyle characteristics,
i.e. leisure physical activity index, smoking status, or education
attainment, prevalent coronary heart disease, and parental history
of diabetes were not associated with lactate quartiles.
Higher lactate was associated with both BMI and waist
circumference (both P,0.001) (Table 1). With regard to lipids,
LDL cholesterol did not vary significantly across lactate quartiles
(P = 0.38), while triglycerides concentrations were greater, and
HDL levels lower, with successive lactate quartiles (P for trend of
,0.001 and 0.04, respectively) (Table 1). Fasting glucose and
fasting insulin also demonstrated significant positive trends by
lactate quartile (both P,0.001) (Table 1). In linear regression,
BMI, waist circumference, triglycerides, fasting glucose and fasting
insulin were also positively associated with plasma lactate, while
HDL cholesterol was negatively associated with plasma lactate
(Table 2). Similarly, the HOMA-IR (Figure 1) was higher with
successive lactate quartiles (P,0.001).
There was a graded relationship between plasma lactate at
baseline and the cumulative risk of incident type 2 diabetes over an
average 7.9 years of follow-up (Figure 2). This graded relation-
ship was robust after simultaneous adjustment for diabetes risk
factors (Table 3, Models 1–4). In models adjusting for medical
history, anthropometric variables and lipids, the association was
attenuated but remained significant and strong (4th quartile HR
2.05; 95% CI: 1.28, 3.28; P-trend #0.001). Histogram comparison
revealed an upward shift in the distribution of lactate in diabetic
cases versus non-diabetics (Figure 3). Similarly, a restricted cubic
spline demonstrated an increase in the relative hazard for diabetes
with increasing lactate levels, particularly below the 75th percentile
of the lactate distribution, i.e. a plasma lactate of 9.7 mg/dL.
Models examining the metabolic pathway between lactate and
incident diabetes are shown in Table 3. The inclusion of fasting
insulin as a covariate (Model 5b) attenuated the dose-response
trend (4th quartile HR 1.46, P-trend = 0.06), while the inclusion of
fasting glucose (Models 5a & 5c), resulted in a non-significant
reversal of the association (Model 5a: 4th quartile HR 0.77, P-
trend = 0.45; Model 5c: 4th quartile HR 0.66, P-trend = 0.26).
A sensitivity analysis defining diabetes on the basis of diabetes
medication use and self-report of physician diagnosis, i.e.
excluding the subclinical cases identified by glucose measures,
increased the magnitude of the association between lactate and
incident diabetes (Table S1). In fact, even after adjusting for
fasting insulin, lactate still demonstrated a significant trend across
quartiles (P-trend = 0.02).
Discussion
This analysis represents the largest population-based examina-
tion of the prospective relationship between lactate and type 2
diabetes. We observed a strong, graded relationship between
plasma lactate and subsequent risk of incident type 2 diabetes over
a 9-year follow-up period. The graded association, which was
observed across the normal clinical range of lactate values, was
independent of many traditional diabetes risk factors.
Prior to the current report there were several cross-sectional,
clinical studies that found an association between lactate and
insulin resistance [10,11] as well as diabetes [9]. Furthermore, one
prospective study of 766 Swedish men, found that an elevated
lactate was associated with 2.4 times the risk of diabetes [13].
However, these studies were small and not readily generalizable.
Strengths of our study include its large, biethnic community-based
population of men and women with high quality measures of
potential confounders.
In our study, we measured blood lactate levels in a population-
based sample of resting subjects after an overnight fast and found
that variations in the normal range (,18 mg/dl) were predictive of
incident diabetes. Lactate is a product of glycolysis that rises
markedly in states of hypoxia such as ischemia [22], with exercise
[23], as well as with acute elevations in glucose and insulin [24,25].
In contrast, plasma lactate in the rested, fasted state represents a
balance between gluconeogenesis [26] and the rate of extrahepatic
glycolysis [25]. A rise in resting lactate can be observed when
gluconeogenesis is disrupted by alcohol use [27] or genetic
disorders [28,29]. Higher resting lactate concentrations may also
be seen with increased extrahepatic glucose disposal or glycolysis
[25] or with an increase in the concentration of lactate due to
hypoxia [30], or oxidative insufficiency [31].
In the fasted, resting state, lactate is produced primarily by
skeletal muscle and adipose tissue, and to a lesser extent by the
brain, ethryrocytes, liver, gut, kidney, and skin [4,25]. While
skeletal muscle accounts for the majority of lactate release [24], a
major determinant of variation in plasma lactate concentration is
the rate of glucose disposal in extramuscular tissues [25]. This is
exemplified by a comparison of obese and non-obese persons, in
which greater lactate concentrations are due to increased lactate
production from adipose tissue [24]. In addition to increased
disposal, increased adiposity is associated with intracellular
hypoxia [30] due to increased adipocyte size [32,33] and
inadequate vascularization [34]. Both these factors – excess
glucose disposal and increased anaerobic glycolysis contribute to
elevations in fasting lactate. However, we observed a relatively low
correlation between BMI or waist circumference and lactate as
well as a graded relationship between lactate and incident diabetes
even after adjusting for measures of adiposity. This suggests that
lactate is more than a marker of BMI or waist circumference.
There is strong evidence that oxidative insufficiency, evidenced
by elevated plasma lactate concentrations, is associated with
diabetes risk. Studies have found smaller mitochondrial size and
lower density among adults with type 2 diabetes [35,36] and
Lactate and Incident Diabetes
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individuals with insulin resistance [37]. Furthermore, there is
evidence that mitochondria are less active in diabetic adults
[36,38]. Despite these associations, the temporal relationship
between mitochondrial function and incident diabetes remains
controversial: some argue that insulin resistance precedes and
even induces mitochondrial inefficiency [39]. Since insulin
signaling may improve oxidative capacity by increasing blood
flow and by stimulating mitochondrial biogenesis, decreased
oxidative capacity may be a consequence of decreased insulin
signaling activity [40]. Decreased oxidative capacity is not
universally observed in all patients with insulin resistance [41].
Furthermore, weight loss can decrease insulin resistance without
impacting oxidative capacity and, among those at risk for type 2
diabetes, exercise can increase oxidative capacity without
impacting insulin resistance [42–44].
In contrast to the work just described, there is strong evidence
supporting a causal role for decreased oxidative capacity in the
development of insulin resistance. Experimental manipulation of
the mitochondrial genome in mice results in decreased oxidative
capacity and insulin resistance [45]. Similarly, genetic mutations in
human mitochondrial genes are associated with insulin resistance
[5,6] and diabetes mellitus [46,47]. Several studies have also
shown that decreased oxidative capacity precedes insulin resis-
tance [48]. Moreover, exercise and weight loss [49] as well as
insulin sensitizers like thiazolidinediones [50] improve insulin
resistance, while exerting direct effects on oxidative capacity. Our
study demonstrates that lactate as a marker of decreased oxidative
capacity is associated with progression of insulin resistance.
However, this was not independent of concurrent baseline
measures of fasting glucose and insulin, suggesting that lactate
does not represent a pathway distinct from insulin resistance.
While establishing the temporal relationship between lactate and
insulin resistance should be an important focus of future studies,
our study suggests that studying the markers in concert rather than
as individual causal factors may better reflect the underlying shift
in metabolism that precedes insulin resistance and ultimately
diabetes.
Another potential explanation for the relationship between
lactate and incident diabetes is expression and activity of GLUT4,
the glucose transporter in muscle and fat cells. In response to
insulin, GLUT4 sequesters glucose into muscle and fat cells where
it undergoes glycolysis [51,52]. In certain settings, greater GLUT4
expression is associated with increased lactate production [53].
Furthermore, there is evidence that lactate itself can induce insulin
resistance by suppressing GLUT4 expression [54]. Confirmation
of this hypothesis is beyond the scope of this study, however.
Figure 1. Mean homeostatic model assessment (HOMA-IR) with
95% confidence intervals by baseline plasma lactate quartile.
doi:10.1371/journal.pone.0055113.g001
Figure 2. Kaplan-Meier cumulative incidence plot with follow-
up years as the time axis and incident diabetes as the outcome
stratified by baseline plasma lactate value. A Wald test was
performed to assess for a trend across quartiles of lactate.
doi:10.1371/journal.pone.0055113.g002
Figure 3. Histograms comparing the distribution of lactate in
diabetic cases (DM) versus noncases (non-DM). The solid line
represents a restricted cubic spline of the relative hazard with knots at
25th, 50th, and 75th percentiles. The dashed lines represent the 95%
confidence interval. Model is adjusted for age, sex, race, ARIC study
center, education, hypertension status, history of coronary heart
disease, smoking status, leisure index, parental history of diabetes,
body mass index, waist circumference, triglycerides, low density
lipoprotein cholesterol, and high density lipoprotein cholesterol.
doi:10.1371/journal.pone.0055113.g003
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Adjustment for insulin attenuated the association between
lactate and incident diabetes, while adjustment for glucose non-
significantly inverted the association. The change in direction of
the association of lactate with incident diabetes after including
glucose in models may be due to the role of fasting glucose in our
case definition. When subclinical cases of diabetes were excluded
from the outcome (Table S1), lactate was significantly associated
with incident diabetes independently of insulin. Furthermore,
lactate was no longer inversely associated with incident diabetes
after adjustment for glucose, albeit non-significant. Whether this
attenuation is due to loss in power from fewer cases or that
lactate is not independent of glucose requires a larger study
population.
Several limitations should be considered in the interpretation of
these data. First, lactate was assessed with single plasma specimens
that had been frozen for over 20 years. The effects of long-term
storage on lactate concentration are unknown, and the lack of
repeat measurements limit our ability to assess the within-person
variability of lactate. Furthermore, this study is also limited with
regard to the measurement of glucose and insulin. Although we
attempted to explore glucose and insulin as mediators in the
causal pathway of incident diabetes, our only lactate sample was
measured at the same time as glucose and insulin. As a result, we
were unable to establish temporality, which would be necessary to
differentiate between their role as mediators or confounders of
lactate and diabetes. Moreover, while we adjusted for many
suspected confounders of the relationship between lactate and
incident diabetes, it is possible we did not fully eliminate their
effects. For example, while we adjusted for leisure index, a
measure of physical activity, quantitative assessments of fitness
and aerobic capacity were not performed. As a result, our models
could be affected by residual confounding. Finally, it would have
been informative to measure lactate during the visits between
baseline and the development of diabetes as this could elucidate
trends in lactate preceding and potentially contributing to
incident diabetes.
In conclusion, our results show that lactate is a predictor of
incident diabetes, suggesting a role for oxidative insufficiency in
the pathogenesis of diabetes. Additional research is needed to
determine the temporal relationship between elevated lactate and
impaired fasting glucose and insulin resistance. Furthermore,
future studies should attempt to elucidate the causal mechanism
behind elevated lactate and diabetes pathogenesis.
Supporting Information
Table S1 Hazard ratios (95% confidence intervals) for
developing type 2 diabetes by weighted quartile of
lactate concentrations. Type 2 diabetes defined by self-report
or medication use alone (N = 233).
(DOCX)
Author Contributions
Statistical analysis: SPJ EG. Conceived and designed the experiments: SPJ
GPSS AYC JHY. Performed the experiments: SPJ AYC JHY. Analyzed
the data: SPJ AYC JHY. Contributed reagents/materials/analysis tools:
ERM RCH CMB FLB MIS JSP. Wrote the paper: SPJ JHY.
Table 2. Percent change in plasma lactate per 1 unit increase in physiologic correlates of insulin resistance and Pearson correlation
coefficient between baseline characteristics and log-base 10 transformed lactate.
Percent Change Per 1 Unit Increase* P Pearson’s Coefficient
Body mass index, kg/m2 1.2% ,0.001 0.15
Waist circumference, cm 0.3% ,0.001 0.14
Log10(Triglycerides, mmol/L) 53.0% ,0.001 0.22
HDL cholesterol, mmol/L 25.9% 0.04 20.11
Fasting glucose, mg/dL 1.0% ,0.001 0.26
Log10(Fasting insulin, pmol/L) 20.3% ,0.001 0.31
*Adjusted for age, gender, race, and center.
Note: HDL represents high density lipoprotein.
doi:10.1371/journal.pone.0055113.t002
Table 3. Hazard ratios (95% confidence intervals) for
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Model 1: Age, gender, race, ARIC center, education.
Model 2: Model 1+ diagnosis of hypertension, prevalent coronary heart disease,
smoking status, leisure index, parental history of diabetes.
Model 3: Model 2+ body mass index, waist circumference.
Model 4: Model 3+ log10 triglycerides, low density lipoprotein cholesterol, high
density lipoprotein cholesterol.
Model 5a: Model 4+ fasting glucose.
Model 5b: Model 4+ log10 fasting insulin.
Model 5c: Model 4+ fasting glucose and log10 fasting insulin.
*P-value for trend evaluated using an ordinal variable based on the median
lactate in each quartile.
doi:10.1371/journal.pone.0055113.t003
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